EVELYN HORNE: Open Payments
NPI 1649239880 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 37 payments from 13 companies in 2025. Trend: 2023 $472 · 2024 $860 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $183 |
| Novo Nordisk Inc | 4 | $65 |
| PFIZER INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 3 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Lundbeck LLC | 1 | $27 |
| Medtronic, Inc. | 1 | $16 |
Products named: UBRELVY, QULIPTA, NURTEC ODT, SHINGRIX, SPRAVATO, Ozempic, XIFAXAN, GARDASIL 9.
Industry payments across SC — which companies pay providers there.
